TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway-Reference-Cited by-同舟云学术

TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway

Published:2020-07-25 Issue:12 Volume:42 Page:1061-1069
ISSN:0161-6412
Container-title:Neurological Research
language:en
Short-container-title:Neurological Research

Author:

Sur-Erdem Ilknur¹²,Muslu Kerem¹^ORCID,Pınarbası Nareg¹²,Altunbek Mine³,Seker-Polat Fidan¹²,Cingöz Ahmet¹²^ORCID,Aydın Serdar Onur²^ORCID,Kahraman Mehmet⁴,Culha Mustafa³^ORCID,Solaroglu Ihsan¹²,Bagcı-Önder Tugba¹²^ORCID

Affiliation:

1. Koç University School of Medicine, Istanbul, Turkey

2. Koç University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey

3. Department of Genetics and Bioengineering, Yeditepe University, Istanbul, Turkey

4. Department of Chemistry, University of Gaziantep, Gaziantep, Turkey

Funder

Bilim Akademisi

Türkiye Bilimsel ve Teknolojik Araştirma Kurumu

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/01616412.2020.1796378

Reference41 articles.

1. Molecularly targeted therapy for malignant glioma

2. Cancer drug resistance: an evolving paradigm

3. An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL

4. Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

5. Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier;Oncology Research;2024

2. Silver nanoparticles for the management of neurological diseases;Silver Nanoparticles for Drug Delivery;2024

3. Functionalized Metal Nanoparticles in Cancer Therapy;Pharmaceutics;2023-07-11

4. The Role of Silver Nanoparticles in the Diagnosis and Treatment of Cancer: Are There Any Perspectives for the Future?;Life;2023-02-07

5. Recent Advances in the Development of Nanodelivery Systems Targeting the TRAIL Death Receptor Pathway;Pharmaceutics;2023-02-03